Psychobiotics for Mitigation of Neuro‐Degenerative Diseases: Recent Advancements
Molecular Nutrition & Food Research · 2024
DOI: 10.1002/mnfr.202300461 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Priya Dhyani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dairy Science & Food Technology, Institute of Agricultural Sciences, BHU, Varansi, 121005, India. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Probiotics. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seed Grant Development Scheme 6031.
Abstract (Originalsprache)
Ageing is inevitable and poses a universal challenge for all living organisms, including humans. The human body experiences rapid cell division and metabolism until approximately 25 years of age, after which the accumulation of metabolic by‐products and cellular damage leads to age‐related diseases. Neurodegenerative diseases are of concern due to their irreversible nature, lack of effective treatment, and impact on society and the economy. Researchers are interested in finding drugs that can effectively alleviate ageing and age‐related diseases without side‐effects. Psychobiotics are a novel class of probiotic organisms and prebiotic interventions that confer mental health benefits to the host when taken appropriately. Psychobiotic strains affect functions related to the central nervous system (CNS) and behaviors mediated by the Gut‐Brain‐Axis (GBA) through various pathways. There is an increasing interest in researchers of these microbial‐based psychopharmaceuticals. Psychobiotics have been reported to reduce neuronal ageing, inflammation, oxidative stress, and cortisol levels; increase synaptic plasticity and levels of neurotransmitters and antioxidants. The present review focuses on the manifestation of elderly neurodegenerative and mental disorders, particularly Alzheimer's disease (AD), Parkinson's disease (PD), and depression, and the current status of their potential alleviation through psychobiotic interventions, highlighting their possible mechanisms of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dairy Science & Food Technology, Institute of Agricultural Sciences, BHU, Varansi, 121005, India.
- Department of Food Science and Technology, Chaudhary Devi Lal University, Sirsa, 125055, India.
- Department of Microbiology, CCS Haryana Agricultural University, Hisar, 125 004, India.
- West China School of Medicine, Sichuan University, Chengdu, 610041, China.
- Department of Biotechnology, Chaudhary Devi Lal University, Sirsa, 125055, India.
- Department of Food Technology, Vocational School of Technical Sciences at Mersin Tarsus, Organized Industrial Zone, Tarsus University, Mersin, 33100, Türkiye.
ORCID-Profile: Sanju Bala Dhull, Gulden Goksen
Förderung
- Seed Grant Development Scheme 6031
Zitieren
APA
Dhyani, P., Goyal, C., Dhull, S. B., Chauhan, A. K., Singh Saharan, B., Harshita, Duhan, J. S., & Goksen, G. (2024). Psychobiotics for Mitigation of Neuro‐Degenerative Diseases: Recent Advancements. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300461
Vancouver
Dhyani P, Goyal C, Dhull SB, Chauhan AK, Singh Saharan B, Harshita, et al. Psychobiotics for Mitigation of Neuro‐Degenerative Diseases: Recent Advancements. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202300461
BibTeX
@article{Dhyani2024,
author = {Dhyani, Priya and Goyal, Chhaya and Dhull, Sanju Bala and Chauhan, Anil Kumar and Singh Saharan, Baljeet and Harshita and Duhan, Joginder Singh and Goksen, Gulden},
title = {Psychobiotics for Mitigation of Neuro‐Degenerative Diseases: Recent Advancements},
journal = {Molecular Nutrition & Food Research},
year = {2024},
doi = {10.1002/mnfr.202300461}
}
EUVIMED